Tema腫瘤學主動型ETF CANC 深 滬
已收盤 04-02 16:00:00 美东时间
37.1088
-0.011
-0.03%
華盛通- 最 高37.48
- 今 開36.71
- 成交量 1.73万股
- 最 低 36.71
- 昨 收 37.12
- 總市值 1.70亿
- 52周最高 38.34
- 市盈率 靜 --
- 換手率 0.38%
- 52周最低 22.4604
- 委 比 33.33%
- 總股本 457.00万
- 歷史最高 38.34
- 量 比 0.61
- 振 幅 2.07%
- 歷史最低 20.0759
- 每 手 1
- 風險率 5.07%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-Skeena Gold & Silver Announces Proposed USD$750 Million Senior Secured Notes Offering
BRIEF-Skeena Gold & Silver Announces Proposed USD$750 Million Senior Secured Notes Offering March 31 (Reuters) - Skeena Resources Ltd SKE.TO : SKEENA GOLD & SILVER ANNOUNCES PROPOSED USD$750 MILLION SENIOR SECURED NOTES OFFERING TO REFINANCE FORMER PROJECT FINANCING AND TO FUND PARTIAL BUYBACK OF EX
03-31 20:42
BRIEF-Nuvectis Pharma Announces Upcoming Presentations For Nxp900 At The 2026 American Association
BRIEF-Nuvectis Pharma Announces Upcoming Presentations For Nxp900 At The 2026 American Association March 31 (Reuters) - Nuvectis Pharma Inc NVCT.O : NUVECTIS PHARMA ANNOUNCES UPCOMING PRESENTATIONS FOR NXP900 AT THE 2026 AMERICAN ASSOCIATION FOR CANCER RESEARCH MEETING Source text: ID:nGNX2N59Kd Fur
03-31 20:31
BRIEF-Yy Group Holding (Nasdaq Yygh) Pauses At-The-Market Offering
BRIEF-Yy Group Holding (Nasdaq Yygh) Pauses At-The-Market Offering March 30 (Reuters) - YY Group Holding Ltd YYGH.O : YY GROUP HOLDING (NASDAQ: YYGH) PAUSES AT-THE-MARKET OFFERING YY GROUP HOLDING - TO CANCEL ABOUT 1 MILLION SHARES; OUTSTANDING SHARES TO BE ABOUT 3.3 MILLION YY GROUP HOLDING LTD - C
03-30 22:10
BRIEF-American Fusion Inc. (Otc Amfn), Obtains Court Order Cancelling 1.683 Billion Shares
BRIEF-American Fusion Inc. (Otc Amfn), Obtains Court Order Cancelling 1.683 Billion Shares March 30 (Reuters) - Renewal Fuels Inc AMFN.PK : AMERICAN FUSION INC. (OTC: AMFN), OBTAINS COURT ORDER CANCELLING 1.683 BILLION SHARES, ELIMINATING MORE THAN HALF OF ALL OUTSTANDING COMMON STOCK Source text: I
03-30 21:50
BRIEF-Anixa Biosciences Announces Presentation Of Its Ovarian Cancer Car-T Therapy Clinical Trial
BRIEF-Anixa Biosciences Announces Presentation Of Its Ovarian Cancer Car-T Therapy Clinical Trial March 30 (Reuters) - Anixa Biosciences Inc ANIX.O : ANIXA BIOSCIENCES ANNOUNCES PRESENTATION OF ITS OVARIAN CANCER CAR-T THERAPY CLINICAL TRIAL AT THE SOCIETY OF GYNECOLOGIC ONCOLOGY ANNUAL MEETING ON W
03-30 21:36
BRIEF-Amplia Therapeutics Reports Four Additional Complete Responses And Improved Overall Survival Data In Accent Pancreatic Cancer Trial
BRIEF-Amplia Therapeutics Reports Four Additional Complete Responses And Improved Overall Survival Data In Accent Pancreatic Cancer Trial Amplia Therapeutics Ltd ATX.AX : AMPLIA THERAPEUTICS REPORTS FOUR ADDITIONAL COMPLETE RESPONSES AND IMPROVED OVERALL SURVIVAL DATA IN ACCENT PANCREATIC CANCER TRI
03-23 20:49
BRIEF-Southwest Airlines Says All Southwest Flights Using New York Laguardia Airport Could Experience Delays Or Cancellations Through Monday Due To An Accident Sunday
BRIEF-Southwest Airlines Says All Southwest Flights Using New York Laguardia Airport Could Experience Delays Or Cancellations Through Monday Due To An Accident Sunday March 23 (Reuters) - Southwest Airlines Co LUV.N : SOUTHWEST AIRLINES: ALL SOUTHWEST FLIGHTS USING NEW YORK LAGUARDIA AIRPORT COULD
03-23 20:34
BRIEF-Leonid Radvinsky, OnlyFans Owner, Has Died Of Cancer - Bloomberg News
BRIEF-Leonid Radvinsky, OnlyFans Owner, Has Died Of Cancer - Bloomberg News March 23 (Reuters) - LEONID RADVINSKY, ONLYFANS OWNER, HAS DIED OF CANCER - BLOOMBERG NEWS Source text: https://tinyurl.com/363wrnfm (( Reuters.Briefs@thomsonreuters.com ;))
03-23 20:21
BRIEF-Cyber Enviro-Tech Inc Has Formally Cancelled Its Previously Filed SEC Regulation A Offering
BRIEF-Cyber Enviro-Tech Inc Has Formally Cancelled Its Previously Filed SEC Regulation A Offering March 16 (Reuters) - Cyber Enviro-Tech Inc CETI.PK : CYBER ENVIRO-TECH INC: HAS FORMALLY CANCELLED ITS PREVIOUSLY FILED SEC REGULATION A OFFERING CYBER ENVIRO-TECH INC: STRUCTURE OF OFFERING CREATED SUB
03-16 19:51
BRIEF-Cytomx’S Varsetatug Masetecan (Epcam Probody® Adc) Continues To Demonstrate Positive Data Supporting Potential As A New Treatment Option In Late-Line Colorectal Cancer
BRIEF-Cytomx’S Varsetatug Masetecan (Epcam Probody® Adc) Continues To Demonstrate Positive Data Supporting Potential As A New Treatment Option In Late-Line Colorectal Cancer March 16 (Reuters) - CytomX Therapeutics Inc CTMX.O : CYTOMX’S VARSETATUG MASETECAN (EPCAM PROBODY® ADC) CONTINUES TO DEMONSTR
03-16 19:40
